R Walker. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug CostsDrug Prescriptions/economicsDrugs, Generic/economicsHealth Care CostsHumansQuality of Health CareUnited Kingdom
Substances: See more » Drugs, Generic
Year: 1995 PMID: 10155324 DOI: 10.2165/00019053-199507050-00001
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981